Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Combined use of pharmacophoric models together with drug metabolism and genotoxicity "in silico" studies in the hit finding process.
Balance.
Preliminary Investigation of Gait Initiation and Falls in Multiple Sclerosis.
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.
Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale.
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
OLFACTORY ENSHEATHING GLIA CELL THERAPY AND TUBULAR CONDUIT ENHANCE NERVE REGENERATION AFTER MOUSE SCIATIC NERVE TRANSECTION.
Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo.
Clinical characteristics of optic neuritis in koreans greater than 50 years of age.
Vm24, a Natural Immunosuppressant Peptide Potently and Selectively Blocks Kv1.3 Potassium Channels of Human T Cells.
Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal.
Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis.
Evidence for classic complement activity in neuromyelitis optica.
Effects of Glatiramer Acetate in a Spontaneous Model of Autoimmune Neuroinflammation.
Pain in multiple sclerosis: A systematic review of neuroimaging studies.
Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.
Resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis.
Explaining temporal trends in annualised relapse rates in placebo groups of randomised controlled trials in relapsing multiple sclerosis: systematic review and meta-regression.
Helicobacter pylori and neurological diseases: Married by the laws of inflammation.
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms.
An introduction with medical applications to functional data analysis.
Teriflunomide: A Review of Its Use in Relapsing Multiple Sclerosis.
Socioeconomic status. The relationship with health and autoimmune diseases.
Diagnosis and classification of neuromyelitis optica (Devic's Syndrome).
Pages
« first
‹ previous
…
289
290
291
292
293
294
295
296
297
…
next ›
last »